Childhood cancer treatments may increase obesity risk later
the ONA take:
According to a new study published online early in the journal Cancer, researchers have found that certain treatments used to treat children with cancer may increase their risk for obesity later in life.
For the study, researchers analyzed data from nearly 2,000 cancer survivors previously treated for their disease at St. Jude Children's Research Hospital in Memphis, Tennessee, who had been diagnosed with cancer at least 10 years ago. Results showed that 47% of survivors who had received cranial radiation were obese versus 29.4% of those who had not received cranial radiation.
Researchers found that patients who were treated with cranial radiation plus glucocorticoids, such as prednisone and dexamethasone, had an increased likelihood of obesity. Patients who were younger at the time of diagnosis also had an increased risk for obesity.
The findings may help health care providers identify cancer survivors who are more likely to become obese and guide treatment selection in order to minimize long-term complications.
Certain treatments used to treat children with cancer may increase their risk for obesity later in life.
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- The Integration of Cannabis in Oncologic Care
- CTCs Promising as Biomarker to Identify Lung Cancer Recurrence
- Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer
- Social Functioning Scores for Young Cancer Survivors Remain Lower Than Their Peers
- Mortality Rates Highest Among Youngest Oncology Patients, Particularly Minorities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|